Charmaine Roson - Philippines

“If the product is not listed in Annex A, then the intended use and ASEAN MDD classification rules will be used, and the CDRRHR will confirm or reclassify as needed during the 14 day pre-submission period.”

Charmaine Roson
Principal Consultant
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines Releases New Guidance on Class A Medical Devices

Published on: August 24th, 2021

FDA Releases List of 1,242 Medical Device Categories That Require a CMDN

To further help with clarifying the regulatory requirements for medical device manufacturers seeking market access in the Philippines, the FDA has released a list of Class A 1,242 product categories in Circular 2021-017 on August 16, 2021. Medical device manufacturers of Class A products specified in Annex A or under the ASEAN MDD, must obtain a Certificate of Medical Device Notification (CMDN). This must be done before manufacturing, distributing, importing, selling, and/or advertising the medical device. If the product is not listed in Annex A, then the intended use and ASEAN MDD classification rules will be used, and the CDRRHR will confirm or reclassify as needed during the 14 day pre-submission period. Classification of a medical device is subject to change if features of a product, such as intended use or duration of use, were to change.

This guidance will take effect fifteen (15) days after its publication in a newspaper of general circulation and when three (3) certified copies are filed to the UP Law Center.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia and with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests for the Philippines.

Blog Posts

China’s NMPA Updates Medical Device Classification Catalogue

China’s National Medical Products Administration (NMPA) maintains a list of all medical device categories called the Medical Device Classification Catalogue. NMPA published a notice on August 17, 2023, that they had released amendments to the Medical Device Classification Catalogue. It’s important for manufacturers to understand these changes as they can significantly impact the cost and time to register medical devices.

Thai FDA Drafting New Guidance for SaMD and AI Device Registration

Thai FDA is drafting new guidelines for AI Regulation. The novel characteristics of artificial intelligence (AI) software cause issues with the medical device registration process in most countries. The Thai Food and Drug Administration (Thai FDA) is working to address this important issue, most recently by hosting a meeting with interested parties on July, 2023, which Asia Actual Thailand employees were invited to attend.

China NMPA Adds 47 Products to Clinical Trial Exemption List

China’s National Medical Products Administration (NMPA) updated its clinical trial exemption list, adding 47 products. The NMPA updates this list every two to three years, with the last amendment in 2021. This brings the total number of clinical trial exempted product categories in China to 1,025.